Related Experiment Video
Updated: Jun 15, 2026

Application of Consistent Massage-Like Perturbations on Mouse Calves and Monitoring the Resulting Intramuscular Pressure Changes
Published on: September 20, 2019
[Muscle relaxants]
1Avdeling for anestesi, Oslo universitetssykehus, Aker 0514 Oslo, Norway. tom.heier@medisin.uio.no
Muscle relaxants, introduced in 1942, aid surgical relaxation by blocking nerve-muscle signals. While generally safe, some like suxamethonium have side effects, and optimal agents are still sought.
Area of Science:
- Anesthesiology
- Pharmacology
- Medical History
Context:
- Muscle relaxants have been integral to clinical anesthesia since 1942.
- Their development traces back to South American curare compounds, with d-tubocurarine isolated in 1935.
Purpose:
- To provide a comprehensive overview of muscle relaxant history.
- To detail their mechanisms of action.
- To discuss their current role in anesthetic practice.
Summary:
- Muscle relaxants, such as suxamethonium and curare derivatives, function by disrupting nerve-muscle signaling to induce skeletal muscle paralysis.
- They facilitate surgical procedures by providing muscle relaxation, an effect that can reduce the need for higher anesthetic doses.
- These agents do not possess anesthetic or analgesic properties and do not affect consciousness.
Impact:
- Muscle relaxants are generally safe when administered correctly, though suxamethonium carries risks of severe adverse events.
- Their use is common during anesthesia induction but less frequent during surgery due to the inherent muscle-relaxing effects of modern anesthetics.
Related Concept Videos
Classification of Skeletal Muscle Relaxants
Peripherally acting skeletal muscle relaxants interfere with the neurotransmission at the neuromuscular end plate to induce paralysis during...
Skeletal Muscle Relaxants: Therapeutic Uses
Centrally Acting Muscle Relaxants: Therapeutic Uses
Centrally acting drugs are classified into spasmolytic and antispasmodic drugs. Spasmolytic drugs such as baclofen, diazepam, and tizanidine inhibit spinal motor neurons and decrease muscle tone. Spasmolytic drugs are administered for severe and chronic spasms due to multiple sclerosis, cerebral palsy, stroke, and spinal cord and muscle injuries. However,...
Peripherally and Centrally Acting Muscle Relaxants: A Comparison
Centrally acting muscle relaxants can be further divided into spasmolytic and antispasmodic drugs. Spasmolytic drugs,...
Skeletal Muscle Relaxants: Adverse Effects
Unlike...
Directly Acting Muscle Relaxants: Dantrolene and Botulinum Toxin
The binding of dantrolene to the RYR1...

